Invitrogen Launches Xenogeneic-Free Media for Human Embryonic Stem Cell Culture
January 13, 2009
Invitrogen, a division of Life Technologies Corporation (NASDAQ:LIFE), announced today that it has launched KNOCKOUT™ SR XenoFree Media for use in the culture of human embryonic stem cells (hESCs). Until now, most of the research carried out on hESCs has used mouse-derived feeder cells and culture media containing components derived from bovine sources. Ideally, hESCs [...]
Illumina Announces High Density Expansion to iSelect® Custom Genotyping Platform
January 13, 2009
Illumina, Inc. (NASDAQ:ILMN) today launched the Infinium® HD (High Density) iSelect Custom Genotyping solution. Researchers now have the flexibility to screen SNPs ranging from 3,000 to 200,000 in focused genotyping studies for both human and non-human species. This higher-density iSelect Custom Genotyping technology is the most versatile solution of its kind in the industry. It [...]
January 13, 2009
Novel Technology Designed to Optimize Early Detection of Potentially Fatal Immune System Dysfunction in Infants SAN FRANCISCO & SAN DIEGO--The Immune Tolerance Institute, Inc. (ITI), and Sequenom, Inc. (NASDAQ: SQNM), today announced a collaboration to develop an advanced newborn screening test for severe combined immunodeficiency (SCID) based on the pioneering work of Jennifer Puck, MD, [...]
Cepheid Announces Preliminary 2008 Fourth Quarter and Full Year Revenue Results
January 13, 2009
SUNNYVALE, Calif., Jan. 13 -- Cepheid (Nasdaq: CPHD) today announced preliminary revenue results for its 2008 fourth quarter and full year ended December 31, 2008. Based on the company's preliminary financial results, total revenue for the fourth quarter of 2008 is expected to be approximately $38 million, with total product revenue of approximately $36 million. [...]
Evogen and LGC License High Sensitivity Novel HyBeacons® PCR Probe Technology
January 13, 2009
Evogen, Inc., a global molecular diagnostics company, and LGC, an international science-based company and recognised provider of laboratory services and measurement standards, announced today that they have signed a worldwide license agreement of LGC’s HyBeacons® PCR probe chemistry technology to Evogen to augment the recently launched rapid molecular diagnostics and detection platform, including the flagship [...]
New Promega Maxwell® 16 LEV Systems Make Quick Work of Difficult Samples
January 13, 2009
MADISON, Wis.--Designed to work with difficult samples, Promega Corporation now offers two new Maxwell® 16 Nucleic Acid Purification Systems: -Maxwell® 16 Cell Low Elution Volume (LEV) DNA Purification Kit -Maxwell® 16 FFPE Tissue LEV DNA Purification Kit The new Maxwell 16 Systems give clinical and research laboratories a more comprehensive offering of fully automated DNA [...]
Definiens Forms Strategic Partnership With Tessella
January 13, 2009
MUNICH, Germany, OXFORD, England, January 13, 2009 -- Definiens, the number one Enterprise Image Intelligence® company, has formed a systems integration partnership with Tessella, the information technology and consulting services company selected by R&D, science and engineering leaders for business-critical assignments. Under the terms of the agreement, Definiens will train Tessella consultants to deploy and [...]
Eksigent Promotes Remco van Soest to Vice President of Product Management
January 13, 2009
Company Creates New Position as it Gears Up for HPLC Product Line Expansion Dublin, CA, January 13, 2009 - Eksigent, a developer of advanced low-flow fluid delivery technologies for drug discovery and other life science applications, announces that Remco van Soest has been promoted to the Vice President level within the company, continuing to be [...]
Clarient Launches Gene Expression Test for Prostate Cancer
January 13, 2009
Clarient, Inc. (Nasdaq: CLRT), a premier anatomic pathology and molecular testing services resource for pathologists, oncologists, and the pharmaceutical industry, today announced the commercial launch of its new gene expression test for prostate cancer. This new test will be available through Clarient’s PATHSiTETM virtual reporting tool and accessible to the company’s entire pathology network Clarient’s [...]
NextBio Appoints Sergio Gurrieri as Senior Director of Business Development
January 13, 2009
NextBio, provider of the leading life sciences search engine, today announced the appointment of Sergio Gurrieri, Ph.D., as Senior Director of Business Development. In this role, Dr. Gurrieri will be responsible for identifying new growth opportunities and strategic business development initiatives. Dr. Gurrieri joins NextBio with 20 years of experience in life sciences research, marketing [...]

